Post IV Fatigue

Most IV nutritional therapies usually lead to increased energy, reduced pain, and other positive outcomes. However, there are rare cases where the opposite reaction occurs. Although this paradoxical response is usually temporary, it can catch patients and providers off guard and may cause disappointment. As a general practice, I inform all new IV patients about this possibility, emphasizing that if it occurs, it provides valuable insights for managing their case.

During the initial consultation, I often use a simple analogy to illustrate the potential outcomes of your first intravenous therapy session. I explain that there are typically three reactions: feeling better, feeling no different, or feeling worse. It’s important to note that none of these responses should be considered negative or alarming. Instead, they merely indicate the state of your internal health at the time of treatment.
The reasons behind feeling worse are numerous, but the following are the most commonly observed in my experience. These reasons are especially prevalent in the sickest patients, regardless of how the physician initially assesses their condition. In other words, when these factors come into play, it usually indicates a very complex and severe illness, regardless of the patient’s outward appearance.

Physiological shifts:

Commonly caused by changes in osmotic gradients, shifts in electrolytes, and the presence of nutrient quantities that exceed the norm for the body. Although these adjustments may still result in issues, they are usually not permanent. Boosting hydration levels and reducing the osmolarity of the patient (using 250-500 mL of 0.45 NS or NS, for instance) can have a significant impact. Slowing down the rate of nutrient administration can also be beneficial, ensuring that the body can tolerate the shifts and exposure. It’s essential to remember that individuals who are unwell have compromised physiology, and even beneficial substances can initially be perceived as threats by the body, leading to reactions.

Immunologic activity:

Many patients with chronic illness or severe illness often have hidden infections or imbalances in their immune system. Even a simple IV, such as a vitamin or mineral infusion, can unexpectedly stimulate the immune system and cause reactions that their suppressed state couldn’t produce. This is particularly true for patients with autoimmune conditions, where the slightest immune activation can trigger a flare-up of symptoms. In such cases, it is important to explain the cause to the patient and assess if they are willing to continue treatment despite potential reactions, with the assurance that the provider will try their best to minimize these reactions.

These reactions may be temporary, but they can be distressing for the patient. If an autoimmune reaction is suspected, it may be necessary to suspend oxidative therapies until the autoimmune activity is addressed. Cytokine manipulators, such as curcumin, artesunate, and glycyrrhizin, may be administered intravenously at lower doses and a slower rate, with additional preparatory IV treatments like hydration with glutathione. In cases where infections are the concern, more extensive testing and oral therapies will be required to both eliminate the infectious agents and support the patient’s overall health. However, the use of oral agents in between IV treatments may not fully prevent early reactions.

Pathway activation:

The sicker a person is, the more nutritionally deficient they become, which slows down all bodily processes. These changes can affect various pathways, including immune response, detoxification, neurotransmission, and more. When sick individuals receive intravenous (IV) nutrient infusions, they may experience pathologically intense detoxification symptoms.

This can cause them to feel even sicker until their body either eliminates or redistributes the toxins, which can be metals or chemicals. The changes in neurotransmission can have widespread effects and lead to unusual symptoms in the brain, muscles, liver, or gut. Additionally, many sick patients may have underlying infections, and IV treatments can release toxins from these pathogens. These toxins are often in the form of metals but can be other harmful substances as well. It is important to approach these reactions with caution and address them gently in the early stages.

Combination reactions:

The three aforementioned cause areas often occur simultaneously, making it challenging to determine their individual impacts. However, it is important to recognize that the reactions experienced by your patient can be attributed to a combination of these causes and may evolve with therapy.

Non-IV support:

Oral support, such as antioxidants, plays a crucial role in navigating through these reactions. In my experience, constipation and dehydration are the two most common physical triggers for these reactions. It’s important to note that many individuals who claim to hydrate often do not do so effectively. This could be due to imbalances or deficiencies in trace minerals, as well as other renal issues. If a person does not have a daily bowel movement, their IV tolerance is likely to be poor, particularly if they are in the “sicker” category. Additionally, poor cell nutrition and sluggish detoxification pathways can contribute to these reactions.

To address these issues, it is essential to promote blood circulation and elimination. This can be achieved through treatments such as colonic therapy, hydrotherapy, lymphatic massage, sauna, and similar approaches.

Other factors:

Although there are various factors that can contribute to a paradoxical reaction, such as fear of medical procedures, fear of recovery, and mental and emotional resistance to therapy in conditions like anorexia nervosa, these situations are less frequent compared to the reasons mentioned above.

Summary:

Upon reviewing a handful years of IV practice, it is important to highlight a specific reaction observed in approximately 5-10% of patients overall. However, in patients who are more critically ill, this reaction may occur in 20-40% of initial IV procedures. To ensure the proper utilization of this valuable information provided by the patient’s body, it is crucial to prioritize patient education, offer support, adapt therapies accordingly, and most importantly, incorporate these reactions into the overall assessment and treatment plan.